Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Distler, Oliver, Highland, Kristin B., Gahlemann, Martina, Azuma, Arata, Fischer, Aryeh, Mayes, Maureen D., Raghu, Ganesh, Sauter, Wiebke, Girard, Mannaig, Alves, Margarida, Clerisme-Beaty, Emmanuelle, Stowasser, Susanne, Tetzlaff, Kay, Kuwana, Masataka, Maher, Toby M.·2019·New England Journal of Medicine

DOI 10.1056/nejmoa1903076

Cited by (1,000)

Items 701–800 of 1,000

Mechanisms of autophagy and their implications in dermatological disorders
Shenghao Xue, Yumeng Lin, Haoran Chen, Zhengyu Yang, Junting Zha, Xuan Jiang, Zhongyu Han, Ke Wang · 2024 · Frontiers in Immunology
Recent advances in TGF-β signaling pathway in COVID-19 pathogenesis: A review
Mahdi Majidpour, Seyed Ghader Azizi, Fatemeh Davodabadi, Mahboobeh Sabeti Akbar-Abad, Zahra Abdollahi, Saman Sargazi, Hossein Shahriari · 2024 · Microbial Pathogenesis
Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic Sclerosis
Barbara White, Daniel E. Furst, Tracy Frech, Masataka Kuwana, Laura Kathleen Hummers, Wendy Stevens, Suzanne Kafaja, Eun Bong Lee, Oliver Distler, Dinesh Khanna et al. · 2025 · ACR Open Rheumatology
The adoption of nintedanib in systemic sclerosis: the SENSCIS study
Teresa Bruni, Francesco Varone · 2020 · Breathe
Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances
Masaru Kato, Ayako Sugimoto, Tatsuya Atsumi · 2020 · Expert Review of Clinical Immunology
Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases
Abdulrahman Ibrahim, Ahmed Ibrahim, Tanyalak Parimon · 2021 · Diagnostics
Interstitial lung disease in systemic sclerosis (systemic scleroderma)
L. P. Ananyeva, Igor E. Tyurin, OLGA A KONEVA, LIUDMILA GARZANOVA, Aleksander M. Lila · 2021 · Modern Rheumatology Journal
Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study
Vasiliki-Kalliopi Bournia, Anastasios Kallianos, Stylianos Panopoulos, ELIAS J. GIALAFOS, Lemonia Velentza, Panayiotis G. Vlachoyiannopoulos, Petros Paul Sfikakis, Georgia Trakada · 2021 · Rheumatology International
An update on interstitial lung disease
Dalia Mudawi, Karl Heyes, Robert Hastings, Pilar Rivera‐Ortega, Nazia Chaudhuri · 2021 · British Journal of Hospital Medicine
Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: a prospective observational study
Adelle S. Jee, Matthew J S Parker, Neil W McGill, Jane F. Bleasel, Susanne E. Webster, Lauren K. Troy, Tamera Jo Corte · 2021 · ERJ Open Research
Impact of Sex and Gender on Autoimmune Lung Disease: Opportunities for Future Research: NHLBI Working Group Report
Elizabeth R. Volkmann, Jill M. Siegfried, Tim Lahm, Corey E. Ventetuolo, Stephen C. Mathai, Virginia D. Steen, Erica L. Herzog, Rebecca M. Shansky, Montserrat C. Anguera, Sonye Karen Danoff et al. · 2022 · American Journal of Respiratory and Critical Care Medicine
Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort study
Shervin Assassi, Nan Shao, Ziwei Yin, Elizabeth R. Volkmann, Donald F. Zoz, Thomas B. Leonard · 2022 · Medicine
Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis
Marija Geroldinger‐Simić, Shaghayegh Bayati, Emmie Pohjanen, Norbert T. Sepp, Peter Nilsson, Elisa Pin · 2023 · International Journal of Molecular Sciences
Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
K.G. Dsouza, Ranu Surolia, Tejaswini Kulkarni, Fu Jun Li, Pooja Singh, Huaxiu Zeng, Crystal T. Stephens, Abhishek Kumar, Zheng Wang, Veena B. Antony · 2023 · Respiratory Research
Role of rituximab in the treatment of systemic sclerosis: A literature review
Hajime Yoshifuji, Keina Yomono, Yasuhiko Yamano, Yasuhiro Kondoh, Hidekata Yasuoka · 2023 · Modern Rheumatology
Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects
Marco Di Battista, Laura Maria Tavanti, Francesco Pistelli, Laura Carrozzi, Mattia Da Rio, Alessandra Rossi, Lorenzo Puccetti, Antonio Gaetano Tavoni, Chiara Romei, Riccardo Morganti et al. · 2023 · Inflammopharmacology
News and failures from recent treatment trials in systemic sclerosis
Christopher Paul Denton, Philip Yee, Voon Hong Ong · 2020 · European Journal of Rheumatology
Usual interstitial pneumonia: a clinically significant pattern, but not the final word
Brandon T. Larsen · 2022 · Modern Pathology
The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients
Francesco Benvenuti, Elisabetta Zanatta, Jérôme Avouac, Ulf Müller‐Ladner, Franco Cozzi, Anna‐Maria Hoffmann‐Vold, Armando Gabrielli, Oliver Distler, Marco Matucci‐Cerinic, Yannick Allanore et al. · 2020 · Expert Review of Clinical Immunology
European consensus statements for interstitial lung disease in systemic sclerosis – Authors' reply
Anna‐Maria Hoffmann‐Vold, Toby M. Maher, Oliver Distler · 2020 · The Lancet Rheumatology
Development and validation of algorithms to build an electronic health record based cohort of patients with systemic sclerosis
Ann-Marcia C. Tukpah, Jonathan A. Rose, Diane L. Seger, Paul F. Dellaripa, Gary Matthew Hunninghake, David Westfall Bates · 2023 · PLoS ONE
Interstitial lung disease in rheumatic diseases: an update of the 2018 review
Fabiola Atzeni, Alessandra Alciati, Francesco Gozza, Ignazio Francesco Masala, Cesare Siragusano, Nicolò Pipitone · 2024 · Expert Review of Clinical Immunology
Systemic sclerosis–related fecal incontinence: a scoping review focusing on a neglected manifestation
Alain Lescoat, François Zimmermann, Charles D Murray, Dinesh Khanna, Michael Hughes, Zsuzsanna Hortobagyi McMahan · 2024 · Rheumatology
Pathophysiology in Systemic Sclerosis: Current Insights and Future Perspectives
Suzan Al-Gburi, Pia Moinzadeh, Thomas Krieg · 2025 · Sclerosis
Síndrome de Sjögren y afectación pulmonar
Jaume Mestre-Torres, Roser Solans · 2021 · Medicina Clínica
Therapie von Lungenfibrosen bei rheumatischen Systemerkrankungen (neue Therapien)
Katharina Buschulte, Anna‐Maria Hoffmann‐Vold, Rucsandra Dobrota, Philipp Höger, Andreas Krause, Michael Kreuter · 2021 · Zeitschrift für Rheumatologie
Association between bevacizumab with cancer drug therapies and drug-induced interstitial lung disease in patients with solid tumor: A systematic review and meta-analysis of randomized clinical trials
Kazuki Nozawa, Daiki Takatsuka, Yuka Endo, Nanae Horisawa, Yuri Ozaki, Ayumi Kataoka, Haruru Kotani, Akiyo Yoshimura, Masaya Hattori, Masataka Sawaki et al. · 2022 · Critical Reviews in Oncology/Hematology
Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis–associated interstitial lung disease mice
Shintaro Mikami, Yoko Miura, Shinji Kondo, Kosuke Sakai, Hiroaki Nishimura, Hiroyuki Kyoyama, Gaku Moriyama, Nobuyuki Koyama, Hideki Noguchi, Hirotsugu Ohkubo et al. · 2022 · PLoS ONE
Calcineurin inhibitors in systemic sclerosis – a systematic literature review
Nina Hofmann, Robert A. Ambühl, Suzana Jordan, Oliver Distler · 2022 · Therapeutic Advances in Musculoskeletal Disease
Inhibition of discoidin domain receptor 2 reveals kinase-dependent and kinase-independent functions in regulating fibroblast activity
Song Ling, Doyun Kwak, Kevin K. Kim · 2023 · American Journal of Physiology-Lung Cellular and Molecular Physiology
Should we use nintedanib as early therapy in patients with SSc-ILD?
Elisabetta Zanatta, Beatrice Moccaldi, Gabriella Szűcs, Paolo Spagnolo · 2023 · Autoimmunity Reviews
Lung Transplantation in Patients with Previous or Unknown Oncological Disease: Evaluation of Short- and Long-Term Outcomes
Chiara Catelli, Eleonora Faccioli, Stefano Silvestrin, Giulia Lorenzoni, Luca Luzzi, David Bennett, Marco Schiavon, Alessio Campisi, Elena Bargagli, Andrea Dell’Amore et al. · 2024 · Cancers
Systemic sclerosis associated respiratory involvement: Scopus-based analysis of articles in 2013–2022
Bohdana Doskaliuk, Ірина КРЕМІНСЬКА, Yuliya Fedorchenko, Liubomyr Zaiats, Roman Yatsyshyn · 2024 · Rheumatology International
Bibliometric analysis of the pirfenidone and nintedanib in interstitial lung diseases
Jia Liu, Faping Wang, Yiwen Hong, Fengming Luo · 2024 · Heliyon
Aryl Thiophenyl-Sulfonamides as potential therapeutics for multiple sclerosis: PAMPA-based pharmacokinetic predictions and multiligand screening against S1PR3
Francisco Rogênio da Silva Mendes, Damião Sampaio de Sousa, Matheus Nunes da Rocha, Caio Henrique Alexandre Roberto, Márcia Machado Marinho, Hélcio Silva dos Santos, Emmanuel Silva Marinho · 2025 · In Silico Research in Biomedicine
Decreased serum cathepsin S levels in patients with systemic sclerosis‐associated interstitial lung disease
Satoshi Toyama, Takashi Yamashita, Ryosuke Saigusa, Shunsuke Miura, Kouki Nakamura, Megumi Hirabayashi, Takuya Miyagawa, Yuki Fukui, Jun Omatsu, Ayumi Yoshizaki et al. · 2020 · The Journal of Dermatology
Dysregulation of the gene signature of effector regulatory T cells in the early phase of systemic sclerosis
Satomi Kobayashi, Yasuo Nagafuchi, Mai Okubo, Yusuke Sugimori, Hiroaki Hatano, Saeko Yamada, Masahiro Nakano, Ryochi Yoshida, Yusuke Takeshima, Mineto Ota et al. · 2022 · Rheumatology
Towards Treatable Traits for Pulmonary Fibrosis
Thijs W. Hoffman, Jan C. Grutters · 2022 · Journal of Personalized Medicine
Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
Antoniya Kamenova, Αrgyris Τzouvelekis, George A. Margaritopoulos · 2023 · Frontiers in Medicine
Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease
K.G. Dsouza, Amanda S. Alexander, Jubal R. Watts, Tejaswini Kulkarni · 2023 · Multidisciplinary Respiratory Medicine
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
Yoshioki Yamasaki, Masataka Kuwana · 2020 · Expert Review of Clinical Immunology
Gender equity in interstitial lung disease
Leticia Barbosa Kawano-Dourado, Marilyn K. Glassberg, María Molina‐Molina, Mary E. Strek, Marlies S Wijsenbeek, Kerri A. Johannson · 2020 · The Lancet Respiratory Medicine
Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: much caution is warranted
Marco Mura · 2020 · Pulmonary Pharmacology & Therapeutics
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
Hana Štorkánová, Lenka Štorkánová, Adéla Navrátilová, Viktor Bečvář, Hana Hulejová, Sabína Oreská, Barbora Heřmánková, Maja Špiritović, Radim Bečvář, Karel Pavelká et al. · 2021 · Biomedicines
Esophageal Dilation and Other Clinical Factors Associated With Pulmonary Function Decline in Patients With Systemic Sclerosis
Kimberly Showalter, Aileen Hoffmann, Carrie Richardson, David Aaby, Jungwha Julia Lee, Jane E. Dematte, Rishi Agrawal, Hatice Savas, Xiaoping Wu, Rowland W. Chang et al. · 2021 · The Journal of Rheumatology
Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox
Alexandra Nagy, Erik Palmer, Lőrinc Polivka, Noémi Eszes, Krisztina Vincze, Enikő Bárczi, Anikó Bohács, Ádám Domonkos Tárnoki, Dávid László Tárnoki, György Nagy et al. · 2022 · Biomedicines
Epidemiology and Treatment of Systemic Sclerosis in Korea
Seung‐Geun Lee, Ki Won Moon · 2022 · Journal of Rheumatic Diseases
Quantification of Ground Glass Opacities Can Be Useful to Describe Disease Activity in Systemic Sclerosis
Domenico Sambataro, Gianluca Sambataro, Francesca Serena Pignataro, Wanda Maglione, Lorenzo Malatino, Carlo Vancheri, Michele Colaci, Nicoletta Del Papa · 2020 · Diagnostics
The target on B cells in Systemic Sclerosis: a “midsummer dream” to extinguish inflammation and prevent early disease progression to fibrosis
Giacomo Davide De Luca, Alessandro Tomelleri, Lorenzo Dagna, Marco Matucci‐Cerinic · 2021 · Clinical Rheumatology
Scleroderma–Systemic Sclerosis
John Varga, Fredrick M. Wigley · 2023 · Elsevier eBooks
Lung function and skin fibrosis changes as predictors of survival in SSc-associated interstitial lung disease: a EUSTAR study
Vincent Sobanski, Jeska K de Vries-Bouwstra, Anna‐Maria Hoffmann‐Vold, Dörte Huscher, Margarida Alves, Marco Matucci‐Cerinic, Gabriela Riemekasten, Mengtao Li, László Czirják, Otylia Kowal‐Bielecka et al. · 2025 · Rheumatology
Multi‐omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosis
Selena Bouffette, Perrine Soret, Alice R Cole, Emmanuel Nony, Pierre Barbier Saint Hilaire, Grégory Leclerc, Lamine Alaoui, Audrey Aussy, Isabelle Wehrle, Aude Le Gall et al. · 2025 · FEBS Journal
Pain and fatigue in systemic sclerosis: Practical strategies for non-pharmacological management
Francesco Bonomi, Khadija El Aoufy, Silvia Bellando-Randone, Marco Matucci‐Cerinic, Michael Hughes · 2025 · Journal of Scleroderma and Related Disorders
Advances in the Molecular Mechanisms of Pulmonary Fibrosis in Systemic Sclerosis: A Comprehensive Review
María Pilar Iranzo Alcolea, Grisell Starita Fajardo, Mercedes Peña Rodríguez, David Lucena López, Cecilia Suárez Carantoña, María López Paraja, Ana García de Vicente, Adrián Viteri-Noël, Andrés González García · 2025 · International Journal of Molecular Sciences
S2k-Leitlinie „Diagnostik und Therapie der systemischen Sklerose“
Jörg Henes, Swantje Arndt, Melanie Patricia Berger, Michael Czihal, Jörg H. W. Distler, Christian Erbel, Thomas Frieling, Claudia Günther, Isabell Haase, Nicolas Hunzelmann et al. · 2025 · Zeitschrift für Rheumatologie
Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research Statement
Deborah Assayag, Ayodeji Adegunsoye, Yet Hong Khor, Francesco Bonella, Raphaël Borie, Ivette Buendía-Roldán, Nazia Chaudhuri, Kevin F. Gibson, Kerri A. Johannson, Naftali Kaminski et al. · 2025 · American Journal of Respiratory and Critical Care Medicine
Fibroblast‐driven MMP‐9/TIMP‐1 imbalance in bronchoalveolar lavage reflects fibrotic progression in interstitial lung disease
Maria Bianca Bertolotto, Daniela de Totero, Paolo Giannoni, Emanuela Barisione, Marco Grosso, Ennio Nano, Roberto Fiocca, Simona Pigozzi, Elisabetta Tedone, Luca Valle et al. · 2025 · European Journal of Clinical Investigation
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)
L. Petelytska, Lorenzo Tofani, Arthiha Velauthapillai, Rucsandra Dobrota, Mike Oliver Becker, Carina Mihai, Sinziana Muraru, Muriel Elhaï, Suzana Jordan, Eric HACHULLA et al. · 2026 · Annals of the Rheumatic Diseases
Pulmonary hypertension associated with interstitial lung disease: a state-of-the-art review
Ganesh Raghu, Sandeep Sahay, Laura Price, Jason C. Weatherald, Samuel G. Rayner, Jürgen Behr, Athénaïs Boucly, Manisit Das, Vallerie McLaughlin, Franck Rahaghi et al. · 2026 · European Respiratory Journal
Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
Amy Hajari Case · 2022 · Frontiers in Medicine
Can transbronchial lung cryobiopsy benefit adaptive treatment strategies in connective tissue disease-associated interstitial lung disease?
Hideaki Yamakawa, Tamiko Takemura, Shintaro Sato, Makiko Takatsuka, Hiroki Ohta, Tomotaka Nishizawa, Tomohiro Oba, Rie Kawabe, Keiichi Akasaka, Masanobu Horikoshi et al. · 2023 · BMC Pulmonary Medicine
Rituximab compared to intravenous cyclophosphamide in adults with connective tissue disease-associated interstitial lung disease: the RECITAL RCT
Toby M. Maher, Veronica A Tudor, Peter Timothy Saunders, Fernando Zanghelini, Carlota Grossi Sampedro, Georgios Xydopoulos, Michael Gibbons, Sophie V Fletcher, Christopher Paul Denton, Maria A. Kokosi et al. · 2024 · Efficacy and Mechanism Evaluation
EphB2 Receptor Promotes Dermal Fibrosis in Systemic Sclerosis
Érika Said Abu Egal, Séverin Donald Kamdem, Masaaki Yoshigi, Ching‐Chu Yang, Sarah Pellizzari, Ernest M. Kameni, My N. Helms, Shervin Assassi, Mark J. Henkemeyer, Tracy Frech et al. · 2024 · Arthritis & Rheumatology
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease
Kale S. Bongers, Angeline Massett, David N. O’Dwyer · 2024 · Seminars in Respiratory and Critical Care Medicine
A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery
Andrea Grandi, Erica Ferrini, M. Zoboli, Davide Buseghin, Francesca Pennati, Zahra Khalajzeyqami, Roberta Ciccimarra, Gino Villetti, Franco Fabio Stellari · 2024 · American Journal of Physiology-Lung Cellular and Molecular Physiology
A systematic review and meta-analysis of the clinical benefits and adverse reactions of anti-fibrotics in non-IPF progressive fibrosing ILD
Woon Hean Chong, Dipika Agrawal, Ze Ying Tan, Sridhar Venkateswaran, Adeline Yit Ying Tan, Ching Yee Tan, Norris Chun Ang Ling, Noel Stanley Wey Tut Tay · 2024 · Heart & Lung
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives
Alain Lescoat, Monalisa Ghosh, Stephan Kadauke, Dinesh Khanna · 2024 · Expert Review of Clinical Immunology
Actualités dans la physiopathologie de la sclérodermie systémique : vers de nouvelles opportunités thérapeutiques
Kévin Didier, Ailsa Robbins, Frank D. Antonicelli, Bach Nga Pham, Delphine Giusti, Amélie Servettaz · 2019 · La Revue de Médecine Interne
Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype
L. Ananieva, Sergey Nikolaevich Avdeev, Igor E. Tyurin, Aleksander M. Lila, Загребнева Алена Игоревна, А. L. Maslyanskiy, Stanislav A. Terpigorev, I. E. Stepanyan, E. L. Lashina, O. V. Vasilieva et al. · 2021 · Rheumatology Science and Practice
Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: an international collaborative scoping review
Alain Lescoat, Robert David Sandler, François Zimmermann, David Roofeh, Michael Hughes, John David Pauling, Susan Lynn Murphy, Yen T. Chen, Whitney A. Townsend, Maya H Buch et al. · 2022 · Rheumatology
Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors
Cindy Im, Yan Yuan A, Eric D. Austin, Dennis C. Stokes, Matthew J. Krasin, Andrew M. Davidoff, Yadav Sapkota, Zhaoming Wang, Kirsten K. Ness, Carmen Louise Wilson et al. · 2022 · Cancer Research
Progressive pulmonary fibrosis (PPF)
Dursun Duman · 2022 · Tuberkuloz ve Toraks
Development and validation of a Systemic Sclerosis Health Literacy Scale
Meng Zhuang, Chengcheng Li, Shan-Yu Chen, Xin-Hua Tu, Lian Liu, Xi-Lai Chen, Chengwei Xu, Jing Wang · 2023 · Frontiers in Public Health
Pulmonary 5-HT2B receptor expression in fibrotic interstitial lung diseases
Anna Löfdahl, Annika Nybom, Jenny Wigén, Göran Dellgren, Hans Brunnström, Christina Wenglén, Gunilla Westergren‐Thorsson · 2023 · Acta Histochemica
The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis–Associated Interstitial Lung Disease
María Martín-López, Patricia Esmeralda Carreira · 2023 · Journal of Clinical Medicine
Imaging of pulmonary fibrosis in children: A review, with proposed diagnostic criteria
Emily M. DeBoer, Jason P. Weinman, Julia Ley‐Zaporozhan, Matthias Griese, Robin R. Deterding, David A. Lynch, Stephen M. Humphries, Joseph Jacob · 2024 · Pediatric Pulmonology
A role of antifibrotics in the treatment of Scleroderma-ILD?
Katerina M. Antoniou, Athina Trachalaki, Αrgyris Τzouvelekis, Venerino E. Poletti, Eirini Vasarmidi, Petros Paul Sfikakis, Demosthenes E. Bouros · 2019 · Pulmonology
The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease
Paroma Sarkar, Cristina Avram, Nazia Chaudhuri · 2020 · Expert Review of Respiratory Medicine
Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies
Michael Mähler, Kim Grace, Fabrece Roup, Chelsea Bentow, Nicole Fabien, David Gonçalves, Boaz Palterer, Marvin J. Fritzler, Danilo Villalta · 2021 · Immunologic Research
Antifibrotics in systemic sclerosis
María Martín-López, Patricia Esmeralda Carreira · 2021 · Best Practice & Research Clinical Rheumatology
A Drug–Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
Madelon C Vonk, Alfredo Guillén del Castillo, Michael Kreuter, Mandy Avis, Kristell Marzin, Salome Rebecca Mack, Sven Wind, Martina Gahlemann · 2021 · European Journal of Drug Metabolism and Pharmacokinetics
Long-term evaluation of pulmonary function and survival of patients with interstitial pneumonia with autoimmune features
Julio Arturo Huapaya, Afroditi Boulougoura, Julie Fried, Sepehr Mesdaghinia, Brooks J. Culotta, Sara W. Carson, Peter J. Bergquist, Pranay Krishnan, Haijun Wang, Cristina A. Reichner et al. · 2021 · Clinical and Experimental Rheumatology
Mortality Trends in Rheumatoid Arthritis: Zooming in on Interstitial Lung Disease
Pankti D. Reid, Sabina A. Guler · 2021 · Annals of the American Thoracic Society
Is there a therapeutic role for immunosuppression for gastrointestinal involvement in patients with systemic sclerosis?
Zsuzsanna Hortobagyi McMahan, Michael Hughes · 2023 · Rheumatology
Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis
Jenkins, R. Gisli, Cottin, Vincent, Nishioka, Yasuhiko, Noth, Imre, White, Eric S., Ittrich, Carina, Diefenbach, Claudia, Rohr, Klaus B., Selman, Moisés, Maher, Toby M. · 2024 · ERJ Open Research
Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study
Shirish Dubey, Felix Woodhead · 2023 · Rheumatology International
Innovations in the care of childhood interstitial lung disease associated with connective tissue disease and immune‐mediated disorders
Aaida Samad, Holly Wobma, Alicia M. H. Casey · 2024 · Pediatric Pulmonology
An updated overview of Juvenile systemic sclerosis in a French cohort
Léa Jacquel, Rouba Bechara, Joëlle Terzic, Anne-Cécile Rameau, Emmanuel Chatelus, Linda Rossi‐Semerano, Isabelle Koné‐Paut, Ulrich Meinzer, I. Lemelle, Charlotte Rebelle et al. · 2025 · Pediatric Rheumatology
Homocysteine Exacerbates Pulmonary Fibrosis via Orchestrating Syntaxin 17 Homocysteinylation of Alveolar Type II Cells
Jiefeng Huang, Ke Fang, Wuyan Lu, Rongrong Wu, Yuanyuan Chen, Linxiao Li, Zihao Hu, Zixin Cai, Yu Jiang, Xinli Fan et al. · 2025 · Advanced Science
Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)
F. Barde, Kevin Chevalier, Paul Decker, Matéo Merin, Amélie Nicolas, Alain Lescoat, Alban Deroux, Vincent Koether, Emmanuel Chatelus, Cyrille Coustal et al. · 2025 · Journal of Autoimmunity
Nailfold capillaroscopy in patients with systemic sclerosis-associated interstitial lung disease: a substudy of the SENSCIS trial
Vanessa M. Smith, Christopher Paul Denton, Ariane L. Herrick, Carina Ittrich, Margarida Alves, Maurizio Cutolo · 2025 · RMD Open
Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series
Elise Siegert, Elpida Phithak, Fredrik N. Albach, Robert Biesen, Norman Michael Drzeniek, Maria R. Dzamukova, Isabell Haase, Klaus Henrik Søndergaard, Dorothea Schleser, Leonard Fiebig et al. · 2026 · Annals of the Rheumatic Diseases
Utility of phototherapy in patients with systemic sclerosis: Systematic review
Bartosz Miziołek, Michał Tworek, Ewa Łapczyńska, Anna Tekielak, Joanna Kochanowska, Karina Polak, Beata Sylwia Bergler-Czop · 2022 · Dermatologic Therapy
Recent Advances in the Treatment of Interstitial Lung Diseases
Aneesh A Bang, Sonali Bang, Arun Bang, Sourya Acharya, Samarth Shukla · 2023 · Cureus
Systemic scleroderma: Review and updated approach and case description to addressing pulmonary arterial hypertension and idiopathic pulmonary fibrosis: A dual challenge in treatment
Guillermo Cueto‐Robledo, Diana Tovar-Benitez, Ana Alfaro, Leslie-Marisol González-Hermosillo · 2024 · Current Problems in Cardiology
Pulmonary Manifestations of Sjögren's Disease
Louise Byrne, Cormac McCarthy, Aurélie Fabre, Nishant Gupta · 2024 · Seminars in Respiratory and Critical Care Medicine
Exploring the mechanism of luteolin improving immune and inflammatory responses in systemic sclerosis based on systems biology and cell experiments
Xiang Ding, Jian Liu, Xiaolu Chen, Xianheng Zhang · 2024 · International Immunopharmacology
Patient Profile-Based Management with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
Vinod Kumar Viswanathan, Aloke Gopal Ghoshal, Anant Mohan, Ketaki Patil, Chaitanya Bhargave, SANJAY Y. CHOUDHARI, Suyog C. Mehta · 2024 · Pulmonary Therapy
Interstitial Lung Disease Associated with Anti-Ku Antibodies: A Case Series of 19 Patients
Laure Petitgrand, Kaïs Ahmad, Delphine Gamondes, Rémi Diesler, Nicole Fabien, Laure Gallay, Romain Fort, Julie Traclet, François Lestelle, Roland D Chapurlat et al. · 2025 · Journal of Clinical Medicine
Examining Cough’s Role and Relief Strategies in Interstitial Lung Disease
Chee Yao Lim, Sanam Wasim Khan, TAREK ALSIBAI, Gayathri Sathiyamoorthy · 2025 · Journal of Clinical Medicine